Targeting tropomyosin receptor kinase (TRK) in CYLD defective tumours: A placebo-controlled early phase trial with pegcantratinib

Autor:	Neil Rajan
Rok vydání:	2017
DOI:	10.26226/morressier.595a9c56d462b80296c9fb21
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::b3d470b61efc11c9449c62a95769600c https://doi.org/10.26226/morressier.595a9c56d462b80296c9fb21 Zobrazit plný text záznamu